Stats and such Flashcards

1
Q

exposure odds ratio

A

diseased/healthy exposed divided by diseased/healthy unexposed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Interpretation of an odds ratio

A

under the rare disease assumption (100%), we can substitute odds for risk, and odds ration for relative risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the relationship between prevalence and incidence

A

Prevalence=Incidence x disease duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the target population

A

Population to which inferences from the study are to be made.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Source population

A

Population from which study subjects (cases and non-cases) are selected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Effect modification

A

Effect modification is when the effect of A on B depends on C
e.g. the effect of smoking on laryngeal cancer is greater in men than in women EM
as opposed to, the effect of coffee on laryngeal cancer is confounded by smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Measures of disease frequency

A

Measures of disease frequency describe the absolute risk of a disease.
Prevalence,
Incidence rate/Incidence density, and
cumulative incidence/incidence proportion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

measure of association

A

Risk ratio (relative risk , incidence rate ratio), A tool to compare disease rates in two populations
Odds ratios
Risk difference (attributable risk)
The population attributable risk (rate) (PAR) is the risk in the total study population that is attributable to the presence of the exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Logistic regression

A

Logistic regression can describe the relationship between a categorical outcome (response variable) and a set of covariates (predictor variables). The categorical outcome may be binary (e.g., presence or absence of disease) or ordinal (e.g., normal, mild and severe). The predictor variable(s) may be continuous or categorical.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Type 1 error

A

incorrect rejection of a true null hypothesis. (False positive result)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type 2 error

A

is the failure to reject a false null hypothesis (incorrect acception of a false null hypothesis) (false negative result)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

4 Measures of variability

A

There are four different measures of variability, the range, interquartile range, variance, and standard deviation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Variance

A
The average squared difference of the deviance from the mean
1,2,3,4,5
medel 3
-2  -> 4
-1  -> 1
0  -> 0
1  -> 1
2 -> 4
= 10
10/n-1 = 10/4= 2,5
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Standard deviation

A

square root of the variance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sensitivity, specificity, PPV, NPV

A

Sensitivity=sant testpositiva/alla sant positiva
specificity=sant testnegativa/alla sant negativa
PPV= sant Testpositiva/ alla testpositiva
NPV= Sant Testnegativa/ alla testnegativa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Whats the difference between paulines study and yours

A

Basically the same incidence for TNFi (66 vs 62)
I have an active comparator
Dramtic increase in melanoma age-standardized incidence (doubling since 2000, 5 times higher than 1975), almost no change in metastatic melanom and death from melanoma
In the european collaborative project, the inidence rate in Swedish TNFi treated was double that of UK-treated (the two largest registers)
No increase of in situ melanoma in paulines study

17
Q

Active comparator important in your studies (stuyd 3)

A

Results were very stable comparing the different bionaive comparators

18
Q

Potentiell bias i both TMX/AI

A

Samtidigt kan det ju finnas orsaker kopplade till ledvärk som gör att man 1) byter preparat, 2) alternativt att om man inte har utvecklat jobbig ledvärk av ett av preparaten så är man kanske mer villig att testa det andra också.

19
Q

Adjustments in the cc study

A

Betr brca som riskfaktor för senare RA är det eg inte lika viktigt att justera, vår fråga är ju här om OR för brca före RA liknar HR för RA efter brca, oavsett om det förstnämnda är confoundat eller ej.

20
Q

Genetic overlap

A

Both RA and Breast cancer are gentically complex diseases. GWAS studies have indeed identified many candidate genes, but the effect sizes are generally quite small

21
Q

R2

A

proportion of the variance in the dependent variable that is predictable from the independent variable(s

22
Q

AIC

A

AKaika information criterion, a measure of the fit of the model, comparing two models, lower value is better

23
Q

Hazard Hazard ratio

A

Instantaneous risk, ratio of the hazard rates

24
Q

Properties of the normal distribution

A

Normal distributions are symmetric around their mean.
The mean, median, and mode of a normal distribution are equal.
68% of the area of a normal distribution is within one standard deviation of the mean.
Approximately 95% of the area of a normal distribution is within two standard deviations of the mean.

25
Q

Channeling between bDMARDs

A

We see that mortality is higher in non-TNFi cohorts, especially among those that start a non-TNFi as their first bDMARD.
We also see that there is channeling of patients concerning the risk of malignancy (most of which is handled by age/sex + disease severity), but we see that when we compare tnfi switchers to second tnfi or non-tnfi, there is very little channeling beyond age/sex

26
Q

Compliance vid TMX-behandling

A

I en registerstudie var 30% ickekompliant

27
Q

Biverknignar AI TMX

A

TMX, svettningar trombos

AI, ledvärk, osteoporos, torrhet i slidan,